CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities
Net income	$ 990	$ 417
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation, amortization and accretion, net	(42)	(35)
Deferred income tax expense (benefit)	227	(48)
Share-based compensation	42	46
Net realized investment (gains) losses	(1)	(7)
Net trading (gains) losses	(2)	(9)
Loss from equity method investments	4	11
Impairments and provision for loan and credit losses	(1)	5
Net (gains) losses of consolidated investment entities	3	6
Changes in operating assets and liabilities:
Restricted and segregated investments	(158)	(123)
Deferred acquisition costs	12	23
Policyholder account balances, future policy benefits and claims, and market risk benefits, net	448	1,073
Derivatives, net of collateral	(51)	(242)
Receivables	0	256
Brokerage deposits	90	(314)
Accounts payable and accrued expenses	(436)	(219)
Current income tax, net	(44)	80
Other operating assets and liabilities of consolidated investment entities, net	(1)	(6)
Other, net	364	142
Net cash provided by (used in) operating activities	1,444	1,056
Available-for-Sale securities:
Proceeds from sales	0	313
Maturities, sinking fund payments and calls	3,283	1,464
Purchases	(3,972)	(5,098)
Proceeds from sales, maturities and repayments of mortgage loans	32	41
Funding of mortgage loans	(69)	(52)
Proceeds from sales, maturities and collections of other investments	20	31
Purchase of other investments	(23)	(24)
Purchase of investments by consolidated investment entities	(131)	(122)
Proceeds from sales, maturities and repayments of investments by consolidated investment entities	236	182
Purchase of land, buildings, equipment and software	(52)	(41)
Cash paid for written options with deferred premiums	(57)	(59)
Cash received from written options with deferred premiums	15	24
Cash paid for deposit receivables	(9)	(10)
Cash received for deposit receivables	167	210
Other, net	(9)	(5)
Net cash provided by (used in) investing activities	(569)	(3,146)
Investment certificates:
Proceeds from additions	1,638	3,590
Maturities, withdrawals and cash surrenders	(1,881)	(1,822)
Policyholder account balances:
Deposits and other additions	358	339
Net transfers from (to) separate accounts	(26)	(19)
Surrenders and other benefits	(495)	(569)
Change in banking deposits, net	(170)	1,702
Cash paid for purchased options with deferred premiums	(51)	(24)
Cash received from purchased options with deferred premiums	26	8
Issuance of long-term debt, net of issuance costs	0	741
Repayments of long-term debt	(3)	(2)
Dividends paid to shareholders	(138)	(134)
Repurchase of common shares	(628)	(617)
Borrowings of consolidated investment entities	166	0
Repayments of debt by consolidated investment entities	(227)	(31)
Net cash provided by (used in) financing activities	(1,431)	3,162
Effect of exchange rate changes on cash	(5)	11
Net increase (decrease) in cash and cash equivalents, including amounts restricted	(561)	1,083
Cash and cash equivalents, including amounts restricted, at beginning of period	8,620	8,755
Cash and cash equivalents, including amounts restricted, at end of period	8,059	9,838
Supplemental Disclosures:
Income taxes paid, net	25	33
Leased assets obtained in exchange for operating lease liabilities	11	7
Reconciliation of cash and cash equivalents, including amounts restricted:
Restricted and segregated cash, cash equivalents and investments	1,591
Less: Restricted and segregated investments	(738)
Total cash and cash equivalents including amounts restricted per consolidated statements of cash flows	8,059	9,838
Ameriprise Financial
Supplemental Disclosures:
Interest paid	195	112
Reconciliation of cash and cash equivalents, including amounts restricted:
Cash and cash equivalents	7,071
Consolidated investment entities
Supplemental Disclosures:
Interest paid	44	$ 44
Reconciliation of cash and cash equivalents, including amounts restricted:
Cash and cash equivalents	$ 135